Investor insights
Sectors invested in
Funding rounds participated in
$105M sweet spot round size
Most of their 33 investments are in rounds between $70M and $140M
Investor type
Basic info
Industry
Sectors
Investments made
AN2 Therapeutics raised $70M on August 15, 2023
Investors: TCG X, Adage Capital Management, RA Capital Management, L.P., Surveyor Capital, Marshall Wace and Avidity Partners
CG Oncology raised $105M on August 2, 2023
Investors: Decheng Capital, TCG X, Foresite Capital, RA Capital Management, L.P., Malin Corporation plc, Longitude Capital and Avidity Partners
CG Oncology raised $105M on August 2, 2023
Investors: Decheng Capital, Foresite Capital, Malin Corporation plc, Longitude Capital, TCG X, RA Capital Management, L.P. and Avidity Partners
Immunome, Inc. raised $125M on June 29, 2023
Investors: Woodline Partners LP, Redmile Group, Enavate Sciences and Avidity Partners
Aledade, Inc. raised $260M on June 21, 2023
Investors: Venrock, Lightspeed Venture Partners and Avidity Partners
Octave raised $52M on June 15, 2023
Investors: Cigna Ventures, Company, Greycroft, Health Velocity Capital, Obvious Ventures, Novo Holdings, Felicis Ventures and Avidity Partners
Quanta Therapeutics raised $51M on May 22, 2023
Investors: Sofinnova Ventures, Russia technology fund, Longitude Capital, Vida Ventures, LLC, Surveyor Capital and Avidity Partners
Fusion Pharmaceuticals raised $60M on February 13, 2023
Investors: The Invus Group, Woodline Partners LP and Avidity Partners
Karyopharm Therapeutics Inc. raised $165M on December 5, 2022
Investors: Adage Capital Management, HEALTHCOR LTD, Armistice Capital LLC, Surveyor Capital, Marshall Wace and Avidity Partners
Undisclosed raised $140M on December 2, 2022
Investors: Dragoneer Investment Group, Coatue Management and Avidity Partners